Crossref
Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes
Clinical Medicine Reviews in Vascular Health · 2010
DOI: 10.4137/cmrvh.s3372 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Vascular Health, 2010. Verfasst von Baptist Gallwitz.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gallwitz, B. (2010). Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. https://doi.org/10.4137/cmrvh.s3372
Vancouver
Gallwitz B. Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes. Clinical Medicine Reviews in Vascular Health. 2010. doi:10.4137/cmrvh.s3372
BibTeX
@article{Gallwitz2010,
author = {Gallwitz, Baptist},
title = {Sitagliptin and Metformin in Fixed Dose Combination: The Emerging Evidence of its Therapeutic Impact in Type 2 Diabetes},
journal = {Clinical Medicine Reviews in Vascular Health},
year = {2010},
doi = {10.4137/cmrvh.s3372}
}
EUVIMED